Are There Any Approved Nanotechnology-Based Chemotherapeutic Agents?
Yes, several nanotechnology-based chemotherapeutic agents have been approved by regulatory bodies. For example, Doxil is a liposomal formulation of doxorubicin, and Abraxane is a nanoparticle albumin-bound form of paclitaxel. These drugs have shown improved efficacy and reduced side effects compared to their conventional counterparts.
